Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region-Reference-Cited by-同舟云学术

Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region

Published:2019-02 Issue:1 Volume:17 Page:e187-e194
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Maruzzo Marco,Basso Umberto,Borsatti Eugenio,Evangelista Laura,Alongi Filippo,Caffo Orazio,Maines Francesca,Galuppo Sara,De Vivo Rocco,Zustovich Fable,Palleschi Dario,Zivi Andrea,Sava Teodoro,Sorarù Mariella,Iacovelli Roberto,Nicodemo Maurizio,Baier Susanne,Fratino Lucia,Zagonel Vittorina

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference25 articles.

1. Cancer Statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Systemic therapy in men with metastatic castration-resistant prostate cancer: American Society of Clinical Oncology and Cancer Care Ontario clinical practice guidelines;Basch;J Clin Oncol,2014

3. EUROCARE-5 Working Group. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study;De Angelis;Lancet Oncol,2014

4. Radical prostatectomy or watchful waiting in early prostate cancer;Bill-Axelson;N Engl J Med,2014

5. Efficacy, patient-reported outcomes (PROs), and tolerability of the changing therapeutic landscape in patients with metastatic prostate cancer (MPC): a systematic literature review;Seal;Value Health,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and effectiveness of the radium‐223–taxane treatment sequence in patients with metastatic castration‐resistant prostate cancer in a global observational study (REASSURE);Cancer;2024-02-10

2. Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer;Frontiers in Medicine;2022-12-22

3. Radium‐223 dichloride treatment in metastatic castration‐resistant prostate cancer in Finland: A real‐world evidence multicenter study;Cancer Medicine;2022-09-26

4. Total Tumor Volume on 18F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with 225Ac-PSMA-I&T;Biomedicines;2022-04-20

5. Radium-223 in mCPRC patients: a large real-life Italian multicenter study;Minerva Urology and Nephrology;2022-03